Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Shorting Bashers@ playing hand job!!

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Dec 11, 2024 4:23pm

36 Views

Post# 36357529

RE:RE:RE:RE:RE:RE:RE:RE:Shorting Bashers@ playing hand job!!

You'd have to live there to know how horrendous Kamala and Joe are.....but you only need to listen to and be brainwashed by 9 years of lies by CNN and MSNBC to think you know how horrendous DJT is...and judging by the huge mandate given to him by the American people, it's pretty obvious to anyone with a lick of intelligence that you were and are dead wrong.

<< Previous

Bullboard Posts

Next >>

Canada Nickel unveils second of seven resources planned by mid-2025